Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The clinical trial NCT03766321, also known as the FETR-ALS study, is evaluating the potential effect of fecal microbiota transplantation (FMT) on patients with Amyotrophic Lateral Sclerosis (ALS). The trial involves the infusion of fecal microbiota from healthy donors into ALS patients in an attempt to normalize the activity of the gut microbiome and reduce inflammation. The study is a randomized, double-blind, multicenter trial with 42 participants
Mandrioli et al. 2019 Front Neurol. 10: 1021
Primary outcome measures:
Change in Tregs number [ Time Frame: 6 months ]
Published results not found
…